RSS

World Ovarian Cancer Day

The European Medicines Agency (EMA) has approved AstraZeneca and Merck’s Lynparza (olaparib) tablets as maintenance therapy for the treatment of platinum-sensitive relapsed ovarian cancer, regardless of BRCA status. more

News

Ovarian cancer patients are losing out as funding and attention is focused on more prominent women’s diseases, says Australian oncology researcher, Dr Jim Coward, on World Ovarian Cancer Day (8 May). more

News